EquiMax

Package Inserte: FOR ANIMAL TREATMENT ONLY

EQUIMAX^® Oral Gel For Horses

Ivermectin
Praziquantel

 Composition 

One syringe containing 6.42 g of gel

Each gram of Equimax^® contains

Green apple flavour E9802260
Titanium dioxide E171

 Therapeutic indications 

For the treatment of mixed cestode and nematode or arthropod infestations due to adult and immature roundworms, lungworms, bots and tapeworms in horses:

Nematodes :

Large-strongyle:
Strongylus vulgaris (adult and arterial larvae)
Strongylus edentatus (adult and L4 larval stage)
Strongylus equinus (adult)
Triodontophorus spp (adult)

Small-strongyle:
Cyathostomum, Cylicocylus spp., Cylicostephanus spp., Cylicodontophorus spp., Gyalocephalus spp. (adult and non inhibited mucosal larvae)

Parascaris:
Parascaris equorum (adult and larvae)

Oxyuris:
Oxyuris equi (larvae)

Trichostrongylus:
Trichostrongylus axei (adult).

Strongyloides:
Strongyloides westeri (adult)

Habronema:
Habronema spp. (adult)

Onchocerca:
Onchocerca spp. (microfilariae) i.e. cutaneous onchocerciasis

Lungworm:
Dictyocaulus arnfieldi (adult and larvae)

Cestodes (Tapeworm): Anoplocephala perfoliata, Anoplocephala magna, Paranoplocephala mamillana.

Dipteran insects: Gasterophilus spp. (larvae)

As tapeworm infestation is unlikely to occur in horses before two months of age, treatment of foals below this age is not considered necessary.

 Dosage 

200 µg of Ivermectin and 1.5 mg of praziquantel per kg of bodyweight corresponding to 1.07 g of paste per 100 kg bodyweight.

The first division delivers enough paste to treat 100 kg. Each subsequent syringe division delivers enough paste to treat 50 kg of bodyweight. The syringe delivers sufficient paste to treat 600 kg of bodyweight at the recommended dose rate.

 Directions for use 

Before administration, adjust the syringe to the calculated dosage by setting the ring on the plunger. The paste is administered orally by inserting the nozzle of the syringe through the interdental space and depositing the required amount of paste on the back of the tongue. The animal's mouth should be free of any food. Immediately after administration, elevate the head of the horse for a few seconds to ensure the dose is swallowed. 

Veterinary advice should be sought on appropriate dosing programmes and stock management to achieve adequate parasite control for both tapeworm and roundworm infestations.

Bodyweight and dosage should be accurately determined prior to treatment.

 Contraindications 

Do not use in foals under 2 weeks of age.
Do not use in mares from which milk is taken for human consumption.

 Undesirable effects 

Horses carrying heavy infection of Onchocerca microfilariae have experienced such reactions as swelling and itching after treatment. It is assumed that these reactions are the result of the destruction of large numbers of microfilariae.

In case of very high tapeworm infestations, destruction of these parasites may cause a mild transient colic and loose faeces in the treated horse.

Consult your veterinary surgeon if these signs persist.

 Withdrawal period 

Meat and offal: 35 days
Not permitted for use in horses producing milk for human consumption.

 Special warnings 

Avermectins may not be well tolerated in all not target species. Cases of intolerance are reported in dogs, especially Collies, Old English Sheepdogs and related breeds or crosses, and also in turtles and tortoises.

Dogs and cats should not be allowed to ingest spilled paste or access to used syringes due to the potential for adverse effects related to ivermectin toxicity.

As ivermectin is extremely dangerous to fish and aquatic life treated animals should not have direct access to surface water and ditches during treatment.

Parasite resistance to a particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.

This product should only be administered in mares during pregnancy and lactation after assessment of the benefit/risk balance by the veterinarian.

Wash hands after use (to be sure that eye contamination can not occur).

Avoid contact with the eyes. In the case of accidental contact, rinse with abundant quantities of water. In case of eye irritation, seek medical attention.

Do not eat, drink or smoke while handling this product.

In the event of accidental ingestion, seek medical advice and show the doctor the leaflet so that he knows what you have taken.

 Special precautions for storage 

Keep out of the reach and sight of children.
Do not store above 30°C. 
Following withdrawal of the first dose use the product within 6 months. Discard un-used material. Store part used syringes below 25°C.
The product does not contain an antimicrobial preservative.

 Disposal 

Dispose of unused product and containers in accordance with guidance from your local waste regulation authority, e.g., in the UK, the local regional office of the Environment Agency or SEPA. EXTREMELY DANGEROUS TO FISH AND AQUATIC LIFE. Do not contaminate surface waters or ditches with the product or used container.

For animal treatment only.